The AI Eye is an InvestorIdeas.com audio feed focused on artificial intelligence as a business, stock-market, and deal-making story. Its recent episodes track AI through public-company announcements, ticker symbols, patent purchases, product claims, and interviews with company representatives or market-analysis voices. The show spends time on familiar AI market leaders, including NVIDIA and Amazon-related news, while also giving attention to smaller or more specialized names. That mix gives it a watchlist quality. One episode reviews the AI market and looks ahead, naming large companies alongside smaller AI stocks such as BigBear.ai Holdings and SoundHound AI. Other updates move through aviation, medical technology, advertising, aerospace, and chip-related AI applications. The show is often dense. It names exchanges, tickers, agreements, revenue figures, software suites, and product codenames in quick succession. Interview editions slow the pace slightly by letting guests explain specific technologies. Danny Rittman appears in conversations about GBT Technologies, Apollo technology, autonomous vehicles, and Magic2, the company's AI-driven electronic design automation software suite. Doug Davis appears in a discussion tied to Bannock's Acquisition Corp., GBT Tokenized Corp., EV Autonomous Group, and a patent purchase agreement. Mansoor Khatib discusses GBT Technologies' IP portfolio and the sale of its Avant! AI technology. Glenn Tompkins discusses AI stocks, the chatbot race, and analysis tools from Vector Vest. Across these episodes, the show repeatedly frames AI as a chain running from hardware to software to applications and commercial execution. It also returns to a basic investor question: which companies are gaining attention, and what claims support that attention? The tone can be promotional and sometimes rough-edged, with disclosures and sponsorship language close to the surface. That is part of the texture. The show is best approached as a stream of AI market signals, company narratives, and interview-driven context, with the repeated caveat that it is not making recommendations to buy or sell securities.